Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Top Cited Papers
Open Access
- 21 April 2020
- journal article
- research article
- Published by Elsevier BV in Cell Host & Microbe
- Vol. 27 (6), 992-1000.e3
- https://doi.org/10.1016/j.chom.2020.04.009
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020 (847422)
- Hellenic Institute for the Study of Sepsis
- ERC (833247)
- Netherlands Organization for Scientific Research
This publication has 13 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsisBMC Medicine, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cellsCancer Immunology, Immunotherapy, 2016
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic SyndromeArthritis & Rheumatology, 2014
- Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemiaCritical Care, 2011
- Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumoniaClinical and Experimental Immunology, 2010
- Effect of the Novel Influenza A (H1N1) Virus in the Human Immune SystemPLOS ONE, 2009
- Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction*Critical Care Medicine, 2009